Literature DB >> 11510771

Quality of life in patients with gastroesophageal reflux disease.

I Wiklund1.   

Abstract

Entities:  

Mesh:

Year:  2001        PMID: 11510771     DOI: 10.1016/s0002-9270(01)02591-6

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  16 in total

1.  Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.

Authors:  Rickard Ekesbo; Svante Sjöstedt; Heléne Sörngård
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  Laparoscopic Nissen fundoplication in patients with nonerosive reflux disease. Long-term quality-of-life assessment and surgical outcome.

Authors:  T Kamolz; F A Granderath; U M Schweiger; R Pointner
Journal:  Surg Endosc       Date:  2005-02-03       Impact factor: 4.584

Review 3.  Endoscopic treatment modalities for gastroesophageal reflux disease.

Authors:  R E Lutfi; A Torquati; W O Richards
Journal:  Surg Endosc       Date:  2004-07-15       Impact factor: 4.584

4.  [Nonerosive and erosive gastroesophageal reflux disease. Long-term results of laparoscopic anterior semifundoplication].

Authors:  I Gockel; A Heintz; M Domeyer; W Kneist; T T Trinh; T Junginger
Journal:  Chirurg       Date:  2007-01       Impact factor: 0.955

5.  Therapeutic effects of laparoscopic fundoplication for nonerosive gastroesophageal reflux disease.

Authors:  Nobuo Omura; Hideyuki Kashiwagi; Fumiaki Yano; Kazuto Tsuboi; Yoshio Ishibashi; Naruo Kawasaki; Yutaka Suzuki; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

6.  The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): responsiveness to change and English language validation.

Authors:  Peter Wahlqvist; Gordon H Guyatt; David Armstrong; Alessio Degl'innocenti; Diane Heels-Ansdell; Samer El-Dika; Ingela Wiklund; Carlo A Fallone; Lisa Tanser; Sander Veldhuyzen van Zanten; Peggy Austin; Alan N Barkun; Naoki Chiba; Holger J Schünemann
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 7.  The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review.

Authors:  Manishi Prasad; Anne M Rentz; Dennis A Revicki
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  Psychometric validation of the italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease.

Authors:  Károly R Kulich; Carlo Calabrese; Franco Pacini; Sergio Vigneri; Jonas Carlsson; Ingela K Wiklund
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

9.  Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting.

Authors:  Javier P Gisbert; Alun Cooper; Dimitrios Karagiannis; Jan Hatlebakk; Lars Agréus; Helmut Jablonowski; Javier Zapardiel
Journal:  Health Qual Life Outcomes       Date:  2009-07-02       Impact factor: 3.186

10.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.